
CMS Energy keeps earnings outlook alongside US$27B resource plan
The utility retains its US$24 billion capital plan while separating operating demand from signed load additions in a 745 MW total.

Newmont's cost outlook and Agnico Eagle's Oct. 28 results offer company tests as gold investors await the Federal Reserve's decision.

The utility retains its US$24 billion capital plan while separating operating demand from signed load additions in a 745 MW total.

The payment represents 25 per cent of the development contract value, following customer approval by the end of the third quarter.
Direct stablecoin minting and redemption remain planned, while the companies explore supply chain finance with C2FO.
A recent reverse split rules out a 180-day compliance period, while Enlivex says a timely hearing request would preserve trading pending the hearing.

Future task orders will set TRISO fuel quantities and delivery dates, while Antares targets Mark-1 electricity production in 2027.

The interval exceeds modelled grades inside the conceptual pit, while a daughter hole extends the breccia system 184 metres west.

US$187.7M in cash supports planned operations as two fully enrolled autoimmune trials approach readouts and a third study awaits its start.

Australian government lenders back part of a proposed A$200 million debt package, with commercial financing and final approvals still required.
Indiana-made cells and modules are due by the end of 2026, ahead of the buyer's planned construction starts in 2027.
Adjusted operating income turned positive, but an insurance benefit lifted cash generation and the IFRS net loss reached C$50.8 million.
The denial leaves the state water-quality certification vacated, while Williams' project page still targets service in late 2027.
RAM's work includes electrical upgrades and commissioning support, with mill refurbishment targeted for the fourth quarter of 2027.
The proposed hardware and software combination is expected to close in the first half of 2027, subject to regulatory approvals.
About 60,000 employees are reportedly eligible, with decisions due in early December and departures set for Dec. 31.
The venture's first customer has paid an undisclosed deposit for Dallas GPU capacity expected to deploy in late December or early January.
Gold, silver, uranium, lithium, copper and rare earths: the producers, the developers and the projects behind them.
View all
The South Texas satellite plant and first wellfield are built, with uranium extraction expected shortly after receipt of the final permit.
Medical and pharmaceutical developments, psychedelics, and the research and safety questions around them.
View all
A planned 72-participant study will test four subcutaneous doses, with safety and tolerability assessed over 48 weeks.
Technology, computing, crypto and cannabis, and the listed companies moving in them.
View all
CoreWeave's Oct. 27 announcement gives no local customer revenue, project costs or billing dates for the Copenhagen deployment.
Profit fell from US$505 million a year earlier, while cash, stablecoins and Treasuries reached US$4.9 billion.
Uranium, lithium, oil and gas, hydrogen and the grid: the fuels and the companies behind them.
View all
Eco DC Solutions says capacity would exceed 2.1 GW; its Oct. 26 release omits equipment prices, binding purchase terms and delivery dates.

Google will fund flexible household and business resources in PJM, but the companies disclose no price or delivery schedule.

Fortum's jointly owned disposal company must complete commissioning and pass a STUK inspection before operations can begin.
Licensed producers, retail, policy, and the psychedelics companies moving through the clinic.
View all
Directors retain discretion over the ratio for common and exchangeable shares, with no effective date set in the voting disclosure.

The capsules are intended for three programs, including a Canadian Phase 3 PTSD trial of up to 100 people expected to begin in 2027.

The province estimates illegal retailers take 30 per cent of cannabis sales and proposes inspection, seizure and penalty powers for the AGCO.

The bid offers US$1 in cash plus 0.4013 Curaleaf shares for each Aurora share, with a Dec. 4 tender deadline.